Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.4 | 4e-27 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.6 | 2e-21 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-20 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-17 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.53 | 1e-15 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.51 | 7e-15 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.43 | 2e-11 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-11 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-11 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-10 |